CRMD On Watch SPRO On Track To Initiate Phase 3 Trial BMRA\'s Sales Drop

CRMD On Watch, SPRO On Track To Initiate Phase 3 Trial, BMRA's Sales Drop

21:40 EDT 16 Oct 2018 | RTTNews

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

More From BioPortfolio on "CRMD On Watch, SPRO On Track To Initiate Phase 3 Trial, BMRA's Sales Drop"